Key events in cancer: Dysregulation of SREBPs.

Li, Yunkuo; Wu, Shouwang; Zhao, Xiaodong; Hao, Shiming; Li, Faping; Wang, Yuxiong; Liu, Bin; Zhang, Difei; Wang, Yishu; Zhou, Honglan

Li, Yunkuo; Wu, Shouwang; Zhao, Xiaodong; Hao, Shiming; Li, Faping; Wang, Yuxiong; Liu, Bin; Zhang, Difei; Wang, Yishu; Zhou, Honglan.

Afiliação

Li Y; Department of Urology, The First Hospital of Jilin University, Changchun, China.
Wu S; Department of Urology, The First Hospital of Jilin University, Changchun, China.
Zhao X; Department of Urology, The First Hospital of Jilin University, Changchun, China.
Hao S; Department of Urology, The First Hospital of Jilin University, Changchun, China.
Li F; Department of Urology, The First Hospital of Jilin University, Changchun, China.
Wang Y; Department of Urology, The First Hospital of Jilin University, Changchun, China.
Liu B; Department of Urology, The First Hospital of Jilin University, Changchun, China.
Zhang D; Key Laboratory of Pathobiology, Ministry of Education, Jilin University, Changchun, China.
Wang Y; Key Laboratory of Pathobiology, Ministry of Education, Jilin University, Changchun, China.
Zhou H; Department of Urology, The First Hospital of Jilin University, Changchun, China.

Front Pharmacol ; 14: 1130747, 2023.

Article em En | MEDLINE | ID: mdl-36969840

Palavras-chave

SREBPs; cancer therapy; cholesterol; fatty acids; lipid metabolism

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google